NO20051641L - Improved imaging agents comprising barbituric acid derivatives - Google Patents

Improved imaging agents comprising barbituric acid derivatives

Info

Publication number
NO20051641L
NO20051641L NO20051641A NO20051641A NO20051641L NO 20051641 L NO20051641 L NO 20051641L NO 20051641 A NO20051641 A NO 20051641A NO 20051641 A NO20051641 A NO 20051641A NO 20051641 L NO20051641 L NO 20051641L
Authority
NO
Norway
Prior art keywords
imaging
imaging agents
barbituric acid
acid derivatives
improved imaging
Prior art date
Application number
NO20051641A
Other languages
English (en)
Norwegian (no)
Inventor
Klaus Kopka
Hans-Jorg Breyholz
Stefan Wagner
Michael Schafers
Bodo Levkau
Benedictc Guilbert
Duncan Wynn
Original Assignee
Amersham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Plc filed Critical Amersham Plc
Publication of NO20051641L publication Critical patent/NO20051641L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20051641A 2002-10-08 2005-04-04 Improved imaging agents comprising barbituric acid derivatives NO20051641L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0223249.4A GB0223249D0 (en) 2002-10-08 2002-10-08 Improved imaging agents
PCT/GB2003/004351 WO2004032936A1 (en) 2002-10-08 2003-10-08 Improved imaging agents comprising barbituric acid derivatives

Publications (1)

Publication Number Publication Date
NO20051641L true NO20051641L (no) 2005-06-02

Family

ID=9945439

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051641A NO20051641L (no) 2002-10-08 2005-04-04 Improved imaging agents comprising barbituric acid derivatives

Country Status (10)

Country Link
US (1) US20060120956A1 (ja)
EP (1) EP1549317A1 (ja)
JP (1) JP2006505550A (ja)
CN (1) CN1720050A (ja)
AU (1) AU2003273505B2 (ja)
CA (1) CA2501136A1 (ja)
GB (1) GB0223249D0 (ja)
NO (1) NO20051641L (ja)
RU (1) RU2005109272A (ja)
WO (1) WO2004032936A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006021495A1 (de) * 2006-05-09 2007-11-15 Bayer Schering Pharma Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel zur Diagnose der Alzheimer Krankheit
GB0612333D0 (en) * 2006-06-21 2006-08-02 Ge Healthcare Ltd Radiopharmaceutical products
US10328164B2 (en) 2006-06-21 2019-06-25 Ge Healthcare Limited Radiopharmaceutical products
KR20150017387A (ko) * 2007-05-16 2015-02-16 지이 헬스케어 에이에스 영상화를 위한 표지된 ｈｇｆ 결합성 펩티드
GB0718386D0 (en) * 2007-09-21 2007-10-31 Ge Healthcare As Improved radiopharmaceutical formulation
GB201115937D0 (en) 2011-09-14 2011-10-26 Univ Aberdeen 18F-labelled compounds for use as positron emission imaging agents
CN118290322A (zh) * 2018-08-24 2024-07-05 赛尼欧普罗有限责任公司 用于治疗病态状况的芳香型分子

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3952971A (en) * 1971-11-09 1976-04-27 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Airfoil shape for flight at subsonic speeds
US3952091A (en) * 1974-10-23 1976-04-20 Hoffmann-La Roche Inc. Simultaneous multiple radioimmunoassay
GB1527416A (en) * 1976-07-20 1978-10-04 Ciba Geigy Ag Photopolymerisible diepoxides
US6472227B1 (en) * 1986-06-04 2002-10-29 Abbott Laboratories Barbiturate assay, tracers, immunogens, antibodies and kit
US5102786A (en) * 1987-05-21 1992-04-07 Pb Diagnostic Systems, Inc. Biological diagnostic assay system
BR9910468A (pt) * 1998-05-15 2001-01-09 Nycomed Amersham Plc Composto, complexo radiometálico, preparação para administração em ser humano, kit, usos de um composto e de um complexo radiometálico do composto, e, fragmento de peptìdeo
US6656448B1 (en) * 2000-02-15 2003-12-02 Bristol-Myers Squibb Pharma Company Matrix metalloproteinase inhibitors
AU2001265182A1 (en) * 2000-05-30 2001-12-11 Rafael Fridman Inhibitors of matrix metalloproteinases
JP2004512327A (ja) * 2000-10-26 2004-04-22 ファイザー・プロダクツ・インク ピリミジン−２，４，６−トリオン・メタロプロテイナーゼ阻害剤
IL154948A0 (en) * 2000-10-26 2003-10-31 Pfizer Prod Inc Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
JP4173733B2 (ja) * 2000-12-12 2008-10-29 アンジオラボ・インコーポレイテッド 抗−血管新生およびマトリックスメタロプロテイナーゼ阻害活性を有するメリッサ葉抽出物を含む組成物
GB0115929D0 (en) * 2001-06-29 2001-08-22 Nycomed Amersham Plc Solid-phase electrophilic fluorination

Also Published As

Publication number Publication date
AU2003273505B2 (en) 2007-04-19
JP2006505550A (ja) 2006-02-16
US20060120956A1 (en) 2006-06-08
WO2004032936A1 (en) 2004-04-22
CA2501136A1 (en) 2004-04-22
RU2005109272A (ru) 2006-01-27
AU2003273505A1 (en) 2004-05-04
GB0223249D0 (en) 2002-11-13
EP1549317A1 (en) 2005-07-06
CN1720050A (zh) 2006-01-11

Similar Documents

Publication Publication Date Title
NO20051641L (no) Improved imaging agents comprising barbituric acid derivatives
BR9611533A (pt) Lipopoliamina composição e utilização e processo de preparação de uma lipopoliamina
BG103518A (en) 2-(purin-9-yl)tetrahydrofuran-3,4-diol derivatives
NO20064676L (no) Farmasoytiske salter av 3-0-(3'3'-dimetylsuccinyl)betulinsyre
CY1113011T1 (el) Νεα κρυσταλλικη μορφη v της αγομελατινης, μεθοδος παρασκευης αυτης και φαρμακευτικες συνθεσεις που περιεχουν αυτην
NO931631D0 (no) Kompleksdannende midler og maalsoeking av radioaktive immunoreagenser nyttige innen terapeutiske og diagnostiske bildedannende sammensetninger og fremgangsmetoder
WO2005053752A3 (en) Novel imaging agents comprising caspase-3 inhibitors
CY1112401T1 (el) Παραγωγα πυριδαζινης
MXPA04009435A (es) Derivados de quinolina y quinolinona radiomarcados y su uso como ligandos de receptor de glutamato metabotropico.
DE3773237D1 (de) Einen makrozyklischen koordinat und einen antikoerper enthaltende konjugatverbindung.
NO20021205D0 (no) Faste lipid formuleringer
HK1081884A1 (en) Radiolabeled conjugates based on substance p and the uses thereof
WO2001092283A3 (en) Cobalamin compounds useful as cardiovascular agents and as imaging agents
CY1112139T1 (el) Μια φαρμακευτικη συνθεση περιλαμβανουσα κρυσταλλικη ριτοναβιρη μορφη ιι και ενα παρασκευασμα εξ αυτης
DE502005010427D1 (de) Physiologisch aktive zusammensetzung gegen diabetes
CA2450690A1 (en) Improved chelator conjugates
EP2316493A3 (en) Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
CY1107028T1 (el) Παραγωγα ινδανυλ-πιπεραζινων μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα περιεχουν
EE200200281A (et) Pikornaviirusevastased ühendid ja kompositsioonid, nende farmatseutilised kasutusalad ning ained nende sünteesiks
UY30596A1 (es) Marcacion con fluor radioactivo
AU2002350950A1 (en) Compounds for imaging alzheimer's disease
BRPI0408848A (pt) formulações orais de cladribine
NO20004273L (no) Streptograminderivater, deres fremstilling samt preparater inneholdende forbindelsene
JPS57106695A (en) Anthracycline g lycoside compound
BR0315578A (pt) Composição de complexo de tecnécio, produto radiofarmacêutico, kit para a preparação do produto radiofarmacêutico de tecnécio, e, método de formação de imagem de diagnóstico de trombos

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application